Celltrion Symposium: Biosimilar infliximab: Switching from an originator to a biosimilar
Supported by Celltrion

16:00 – 16:50 Industry Symposium: Biosimilar infliximab: Switching from an originator to a biosimilar
Supported by Celltrion

Chairperson Boulos Haraoui, Canada
16:00 Welcome and introduction: Biosimilar
Boulos Haraoui, 
Canada
16:05 Switching from an originator to a biosimilar: Key clinical trials and real world data of biosimilar infliximab
Tore K. Kvien, Norway
16:25 Expanding access to treatment: Pharmacoeconomic of biosimilar infliximab
Michael L. Tee, Philippines
16:40 Q&A, Open discussion